Eastern Bank’s Cytokinetics CYTK Stock Holding History

Eastern Bank’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$852	Buy	+10	New	+$718	﹤0.01%	1001

Other funds holding CYTK

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Eastern Bank's CYTK Position: Q2 2026 in Review

Eastern Bank opened a new position in Cytokinetics (CYTK) in Q2 2026: 10 shares worth $852. The stake represents ﹤0.01% of the portfolio and ranks #1001 among its holdings.

34 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Eastern Bank held 10 shares of Cytokinetics worth $852 as of Q2 2026.
Cytokinetics was a new Eastern Bank position in Q2 2026.
Cytokinetics made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #1001 holding.
34 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.